2019年10月12日(土) 14:50 〜 16:30 第1会場 (メインホール)

Chairs: ‌Makoto SUEMATSU (Japan Agency for Medical Research and Development, Japan), Shigeo OKABE (Dept. of Neurobiology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan), Discussant: ‌George F. KOOB (National Institute on Alcohol Abuse and Alcoholism, USA)

Since Japan has now become a super-aged society, there is a strong demand for revealing the pathogenesis of neuropsychiatric disorders and developing the fundamental treatments for these conditions.
Based on the plan for the Promotion of Medical Research and Development prescribed by the government of Japan, the Medical Research and Development (AMED) promotes integrated R&D in the field of medicine, from basic research to clinical trials, focusing on interrelated areas including neuropsychiatric conditions. In addition to ensuring that outcomes are linked through practical application, it undertakes projects with the aim of comprehensively and effectively establishing and maintaining an environment for this R&D.
The Project for Psychiatric and Neurological Disorders accelerates endeavors aiming to overcome dementia, depression, and other brain disorders. The goal of this project is to establish innovative strategies for diagnosis, prevention, and treatment of brain disorders through the strong promotion of research on neural circuits and brain functions related to the pathophysiology of the brain.
In this symposium, four presenters will discuss the current issues and the future direction of basic and clinical brain science research in Japan.